دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Frequency and Outcomes of Preoperative Stress Testing in Total Hip and Knee Arthroplasty from 2004 to 2017
Daniel S. Rubin, MD, MS; Robert Hughey, MD; Rebecca M. Gerlach, MD; et al.
doi : 10.1001/jamacardio.2020.4311
JAMA Cardiol. 2021;6(1):13-20
Importance Cardiac stress testing is often performed prior to noncardiac surgery, although trends in use of preoperative stress testing and the effect of testing on cardiovascular outcomes are currently unknown.
Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery DiseaseA Subanalysis of the COMPASS Randomized Clinical Trial
Eric Kaplovitch, MD; John W. Eikelboom, MBBS, MSc; Leanne Dyal, MSc; et al.
doi : 10.1001/jamacardio.2020.4390
JAMA Cardiol. 2021;6(1):21-29
Importance Patients with symptomatic lower extremity peripheral artery disease (LE-PAD) experience an increased risk of major vascular events. There is limited information on what clinical features of symptomatic LE-PAD prognosticate major vascular events and whether patients at high risk have a greater absolute benefit from low-dose rivaroxaban and aspirin.
Physiologic and Clinical Features of the Paralympic Athlete’s Heart
Antonio Pelliccia, MD; Filippo Maria Quattrini, MD; Elena Cavarretta, MD; et al.
doi : 10.1001/jamacardio.2020.4306
JAMA Cardiol. 2021;6(1):30-39
Importance Paralympic medicine is a newly adopted term to describe the varied health care issues associated with athletes in the Paralympics. Scarce scientific data, however, are currently available describing the cardiac remodeling in Paralympic athletes.
Effect of Passive Choice and Active Choice Interventions in the Electronic Health Record to Cardiologists on Statin PrescribingA Cluster Randomized Clinical Trial
Srinath Adusumalli, MD, MSc; Julie E. Westover, BS; Douglas S. Jacoby, MD; et al.
doi : 10.1001/jamacardio.2020.4730
JAMA Cardiol. 2021;6(1):40-48
Importance Statin therapy is underused for many patients who could benefit.
Transcatheter Aortic Valve Replacement in Low-risk Patients With Bicuspid Aortic Valve Stenosis
John K. Forrest, MD; Basel Ramlawi, MD; G. Michael Deeb, MD; et al.
doi : 10.1001/jamacardio.2020.4738
JAMA Cardiol. 2021;6(1):50-57
Importance The outcomes of transcatheter aortic valve replacement (TAVR) in low-risk patients with bicuspid aortic valve stenosis have not been studied in a large scale, multicentered, prospective fashion.
Clinical Features and Outcomes of Pregnancy-Related Acute Aortic Dissection
Alan C. Braverman, MD; Eric Mittauer, BS; Kevin M. Harris, MD; et al.
doi : 10.1001/jamacardio.2020.4876
JAMA Cardiol. 2021;6(1):58-66
Importance Women with aortopathy conditions are at risk for pregnancy-related aortic dissection, and these conditions may not be recognized until after the aortic dissection occurs.
Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection Fraction
Matthew W. Segar, MD, MS; Ravi B. Patel, MD, MSc; Kershaw V. Patel, MD; et al.
doi : 10.1001/jamacardio.2020.5592
JAMA Cardiol. 2021;6(1):68-77
Importance Although kidney dysfunction and abnormalities in serum electrolyte levels are associated with poor clinical outcomes in patients with heart failure with preserved ejection fraction (HFpEF), the association of visit-to-visit variability in such laboratory measures with long-term outcomes is unclear.
Associations Between Carotid Artery Plaque Burden, Plaque Characteristics, and Cardiovascular EventsThe ARIC Carotid Magnetic Resonance Imaging Study
Gerd Brunner, PhD; Salim S. Virani, MD, PhD; Wensheng Sun, MPH; et al.
doi : 10.1001/jamacardio.2020.5573
JAMA Cardiol. 2021;6(1):79-86
Importance It remains unknown whether in an asymptomatic community-based cohort magnetic resonance imaging (MRI) measures of plaque characteristics are independently associated with incident cardiovascular disease (CVD) events when adjusted for carotid artery (CA) wall thickness, a measure of plaque burden.
Sociodemographic Disparities in Influenza Vaccination Among Adults With Atherosclerotic Cardiovascular Disease in the United States
Gowtham R. Grandhi, MD, MPH; Reed Mszar, MPH; Farhaan Vahidy, MBBS, MPH, PhD; et al.
doi : 10.1001/jamacardio.2020.3978
JAMA Cardiol. 2021;6(1):87-91
Importance Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of death and disability in the US and worldwide. Influenza vaccination has shown to decrease overall morbidity, mortality, severity of infection, and hospital readmissions among these individuals. However, national estimates of influenza vaccination among individuals with ASCVD in the US are not well studied.
Trends in Utilization and Cost of Low-Density Lipoprotein Cholesterol–Lowering Therapies Among Medicare BeneficiariesAn Analysis From the Medicare Part D Database
Andrew Sumarsono, MD; Hussain S. Lalani, MD, MPH; Muthiah Vaduganathan, MD, MPH; et al.
doi : 10.1001/jamacardio.2020.3723
JAMA Cardiol. 2021;6(1):92-96
Importance Low-density lipoprotein cholesterol (LDL-C)–lowering therapies are a cornerstone of prevention in atherosclerotic cardiovascular disease. With the introduction of generic formulations and the release of new therapies, including proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, contemporary Medicare utilization of these therapies remains unknown.
Five-Year Health Status After Self-expanding Transcatheter or Surgical Aortic Valve Replacement in High-risk Patients With Severe Aortic Stenosis
Suzanne V. Arnold, MD, MHA; Khaja M. Chinnakondepalli, MS; Elizabeth A. Magnuson, ScD; et al.
doi : 10.1001/jamacardio.2020.4397
JAMA Cardiol. 2021;6(1):97-101
Importance In the CoreValve High-Risk Trial, patients with severe symptomatic aortic stenosis had similar clinical outcomes with transcatheter aortic valve replacement (TAVR) vs surgical aortic valve replacement (SAVR) over 5 years of follow-up, with mortality rates of more than 50% in both groups.
Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection
Saurabh Rajpal, MBBS, MD; Matthew S. Tong, DO; James Borchers, MD, MPH; et al.
doi : 10.1001/jamacardio.2020.4916
JAMA Cardiol. 2021;6(1):116-118
Expressing Results From a Mendelian Randomization AnalysisSeparating Results From Inferences
Stephen Burgess, PhD; Christopher J. O’Donnell, MD, MPH; Dipender Gill, BMBCh, PhD
doi : 10.1001/jamacardio.2020.4317
JAMA Cardiol. 2021;6(1):7-8
The National Coverage Decision for MitraClip in Functional Mitral RegurgitationMissing the Mark
Satya Shreenivas, MD; William T. Abraham, MD; Scott Lilly, MD
doi : 10.1001/jamacardio.2020.4762
JAMA Cardiol. 2021;6(1):9-10
Disparities in Influenza Vaccination—Opportunity to Extend Cardiovascular Prevention to Millions of Hearts
Laurence S. Sperling, MD; Michelle A. Albert, MD, MPH; Ram Koppaka, MD, PhD
doi : 10.1001/jamacardio.2020.3983
JAMA Cardiol. 2021;6(1):11-12
Clinical Decision Support in Statin Prescription—What We Can Learn From a Negative Outcome
Thomas M. Maddox, MD, MSc
doi : 10.1001/jamacardio.2020.4756
JAMA Cardiol. 2021;6(1):48-49
Considerations for Optimal Device Selection in Transcatheter Aortic Valve ReplacementA Review
Bimmer E. Claessen, MD, PhD; Gilbert H. L. Tang, MD, MSc, MBA; Annapoorna S. Kini, MD; et al.
doi : 10.1001/jamacardio.2020.3682
JAMA Cardiol. 2021;6(1):102-112
Importance Aortic valve stenosis (AS) is the most common manifestation of acquired valvular heart disease in developed countries. Several large-scale randomized clinical trials investigating the entire spectrum of patients with severe symptomatic AS from low to prohibitive risk have established transcatheter aortic valve replacement (TAVR) as a safe and effective alternative to surgical aortic valve replacement.
A Pregnant Woman With Shortness of Breath
Sarah Chuzi, MD; Patrick Eucalitto, MD; Lynn M. Yee, MD, MPH
doi : 10.1001/jamacardio.2020.5587
JAMA Cardiol. 2021;6(1):113-114
Redefining Left Ventricular Assist Device Indications and Strategies
Nirvik Pal, MD; Mark Nelson, MD; John Butterworth, MD
doi : 10.1001/jamacardio.2020.4303
JAMA Cardiol. 2021;6(1):119
Redefining Left Ventricular Assist Device Indications and Strategies
Muddassir Mehmood, MD
doi : 10.1001/jamacardio.2020.4320
JAMA Cardiol. 2021;6(1):119-120
Redefining Left Ventricular Assist Device Indications and Strategies—Reply
Mandeep R. Mehra, MD, MSc; Daniel J. Goldstein, MD
doi : 10.1001/jamacardio.2020.4323
JAMA Cardiol. 2021;6(1):120-121
Accuracy of New Equation to Calculate Low-Density Lipoprotein Cholesterol
Alagarraju Muthukumar, PhD, DABCC; Lenin Mahimainathan, PhD, MB(ASCP); Parag H. Joshi, MD, MHS
doi : 10.1001/jamacardio.2020.4408
JAMA Cardiol. 2021;6(1):121
Accuracy of New Equation to Calculate Low-Density Lipoprotein Cholesterol
Seth S. Martin, MD, MHS; Mohamed B. Elshazly, MD; Steven R. Jones, MD
doi : 10.1001/jamacardio.2020.4411
JAMA Cardiol. 2021;6(1):121-122
Accuracy of New Equation to Calculate Low-Density Lipoprotein Cholesterol—Reply
Alan T. Remaley, MD, PhD; Maureen Sampson, BS
doi : 10.1001/jamacardio.2020.4445
JAMA Cardiol. 2021;6(1):122-123
Aortic Dissection With Pregnancy—Anticipating Prepartum and Postpartum Risk
Elizabeth McNally, MD, PhD
doi : 10.1001/jamacardio.2020.4884
JAMA Cardiol. 2021;6(1):66-67
Risk Marker Fatigue—Is There an Actionable Outcome?
Sanjiv J. Shah, MD
doi : 10.1001/jamacardio.2020.5616
JAMA Cardiol. 2021;6(1):78
